Follow
David Olmeda
David Olmeda
Sols-Morreale Biomedical Research Centre (IIBm)
Verified email at iib.uam.es
Title
Cited by
Cited by
Year
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
H Peinado, D Olmeda, A Cano
Nature reviews cancer 7 (6), 415-428, 2007
37792007
A molecular role for lysyl oxidase‐like 2 enzyme in snail regulation and tumor progression
H Peinado, M del Carmen Iglesias‐de la Cruz, D Olmeda, K Csiszar, ...
The EMBO journal 24 (19), 3446-3458, 2005
4782005
Snail silencing effectively suppresses tumour growth and invasiveness
D Olmeda, M Jorda, H Peinado, A Fabra, A Cano
Oncogene 26 (13), 1862-1874, 2007
3492007
Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor
M Jordà, D Olmeda, A Vinyals, E Valero, E Cubillo, A Llorens, A Cano, ...
Journal of cell science 118 (15), 3371-3385, 2005
2862005
β-Catenin regulation during the cell cycle: implications in G2/M and apoptosis
D Olmeda, S Castel, S Vilaró, A Cano
Molecular biology of the cell 14 (7), 2844-2860, 2003
2672003
SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells
D Olmeda, G Moreno-Bueno, JM Flores, A Fabra, F Portillo, A Cano
Cancer research 67 (24), 11721-11731, 2007
2652007
The morphological and molecular features of the epithelial-to-mesenchymal transition
G Moreno-Bueno, H Peinado, P Molina, D Olmeda, E Cubillo, V Santos, ...
Nature protocols 4 (11), 1591-1613, 2009
2602009
Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression
AR de Molina, M Bánez-Coronel, R Gutiérrez, A Rodríguez-González, ...
Cancer research 64 (18), 6732-6739, 2004
1712004
UNR/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis
L Wurth, P Papasaikas, D Olmeda, N Bley, GT Calvo, S Guerrero, ...
Cancer cell 30 (5), 694-707, 2016
1632016
Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines
D Olmeda, A Montes, G Moreno-Bueno, JM Flores, F Portillo, A Cano
Oncogene 27 (34), 4690-4701, 2008
1552008
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine
D Olmeda, D Cerezo-Wallis, E Riveiro-Falkenbach, PC Pennacchi, ...
Nature 546 (7660), 676-680, 2017
1502017
Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth
MA Abéngozar, S de Frutos, S Ferreiro, J Soriano, M Perez-Martinez, ...
Blood, The Journal of the American Society of Hematology 119 (19), 4565-4576, 2012
1452012
In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis
I Martínez-Corral, D Olmeda, R Diéguez-Hurtado, T Tammela, K Alitalo, ...
Proceedings of the National Academy of Sciences 109 (16), 6223-6228, 2012
1252012
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway
D Alonso-Curbelo, E Riveiro-Falkenbach, E Pérez-Guijarro, M Cifdaloz, ...
Cancer cell 26 (1), 61-76, 2014
1142014
Hyaluronic acid/chitosan-g-poly (ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery
M Raviña, E Cubillo, D Olmeda, R Novoa-Carballal, E Fernandez-Megia, ...
Pharmaceutical research 27, 2544-2555, 2010
1122010
Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state
D Cerezo-Wallis, M Contreras-Alcalde, K Troulé, X Catena, C Mucientes, ...
Nature medicine 26 (12), 1865-1877, 2020
792020
Zeb1 and S nail1 engage mi R‐200f transcriptional and epigenetic regulation during EMT
A Díaz‐López, J Díaz‐Martín, G Moreno‐Bueno, EP Cuevas, V Santos, ...
International journal of cancer 136 (4), E62-E73, 2015
702015
p62/SQSTM1 fuels melanoma progression by opposing mRNA decay of a selective set of pro-metastatic factors
P Karras, E Riveiro-Falkenbach, E Cañón, C Tejedo, TG Calvo, ...
Cancer Cell 35 (1), 46-63. e10, 2019
562019
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
I Martinez-Corral, L Stanczuk, M Frye, MH Ulvmar, R Diéguez-Hurtado, ...
Angiogenesis 19 (3), 433-445, 2016
552016
Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5
M García-Fernández, P Karras, A Checinska, E Cañón, GT Calvo, ...
Autophagy 12 (10), 1776-1790, 2016
442016
The system can't perform the operation now. Try again later.
Articles 1–20